Ji Sook Park

Title: Ji Sook Park: Innovator in Interferon Beta Purification

Introduction

Ji Sook Park is a notable inventor based in Seoul, South Korea. She has made significant contributions to the field of biotechnology, particularly in the purification of interferon beta. With a total of three patents to her name, her work has implications for therapeutic applications in medicine.

Latest Patents

Ji Sook Park's latest patents focus on processes for purifying human interferon beta from recombinant cultures. One patent describes a method that involves affinity chromatography and cation exchange chromatography. This process includes adsorbing the interferon beta-containing culture to an equilibrated affinity chromatography column, followed by washing with specific buffer solutions. Another patent outlines a similar purification method using affinity chromatography and reversed-phase high-performance liquid chromatography (RP-HPLC). Both patents emphasize the importance of specific pH levels and propylene glycol concentrations in the purification process.

Career Highlights

Throughout her career, Ji Sook Park has worked with prominent companies such as CJ Cheiljedang Corporation and CJ Corporation. Her experience in these organizations has allowed her to develop and refine her innovative techniques in biotechnology.

Collaborations

Ji Sook Park has collaborated with notable colleagues, including Hyung Ki Park and Myung Suk Oh. These partnerships have contributed to her success in the field and have fostered a collaborative environment for innovation.

Conclusion

Ji Sook Park is a distinguished inventor whose work in the purification of interferon beta has advanced the field of biotechnology. Her patents reflect her commitment to innovation and her contributions to medical science.